FDA Roundup: March 22, 2024

SILVER SPRING, Md., March 22, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention)...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: FDA Source Type: news